​

Tarsus Pharmaceuticals Ownership | Who Owns Tarsus Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Tarsus Pharmaceuticals Ownership Summary

Tarsus Pharmaceuticals is owned by 110.71% institutional investors, 3.23% insiders. Rtw investments, lp is the largest institutional shareholder, holding 9.67% of TARS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.87% of its assets in Tarsus Pharmaceuticals shares.

TARS Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTarsus Pharmaceuticals110.71%3.23%-13.94%
SectorHealthcare Stocks 278.45%10.60%-189.04%
IndustryBiotech Stocks 63.84%10.66%25.50%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rtw investments, lp3.41M9.67%$92.75M
Blackrock3.27M9.25%$88.79M
Blackrock funding, inc. /de3.54M9.22%$195.95M
Paradigm biocapital advisors lp2.53M6.60%$140.19M
Jennison associates2.50M6.51%$138.43M
Cowen and company2.20M6.22%$59.72M
Tang capital management2.25M5.87%$124.85M
Vanguard group2.12M5.51%$117.12M
Morgan stanley1.88M5.34%$51.23M
Toronto dominion bank1.91M4.97%$105.71M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tang capital management2.25M8.26%$124.85M
Ally bridge group (ny)173.14K8.22%$9.59M
Paradigm biocapital advisors lp2.53M4.88%$140.19M
Ikarian capital607.69K4.58%$33.65M
Tfg asset management gp200.00K2.73%$11.07M
Cutter capital management, lp112.50K2.55%$6.23M
Sands capital ventures170.00K2.05%$9.41M
Frazier life sciences management1.59M2.02%$43.15M
Ghost tree capital235.00K2.00%$6.39M
Cowen and company2.20M1.64%$59.72M

Top Buyers

HolderShares% AssetsChange
Toronto dominion bank1.91M0.17%1.91M
Lord, abbett1.28M0.22%685.11K
Blackrock3.27M0.00%614.03K
Millennium management644.01K0.02%421.50K
Integral health asset management400.00K1.03%400.00K

Top Sellers

HolderShares% AssetsChange
Exoduspoint capital management, lp---883.04K
Vivo capital---565.55K
Morgan stanley1.88M0.00%-514.23K
J. goldman & co lp130.19K0.19%-427.31K
Ikarian capital607.69K4.58%-422.59K

New Positions

HolderShares% AssetsChangeValue
Toronto dominion bank1.91M0.17%1.91M$105.71M
Integral health asset management400.00K1.03%400.00K$10.87M
Atika capital management177.20K1.04%177.20K$9.81M
Caption management160.00K0.07%160.00K$4.35M
Cutter capital management, lp112.50K2.55%112.50K$6.23M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-5.00
Capital performance advisors llp-5.00
Riggs asset managment-10.00
Allworth financial lp-21.00
Smartleaf asset management-27.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025193-3.02%43,559,2058.22%1101.01%100-16.67%7129.09%
Dec 31, 202462-63.10%11,285,757-73.99%290.23%40-58.33%14-68.18%
Sep 30, 20241689.80%43,393,9218.30%1130.88%962.13%442.33%
Jun 30, 2024153-6.71%40,069,3292.31%1130.92%94-9.62%4334.38%
Mar 31, 202416435.54%39,163,54421.70%1100.92%10438.67%3228.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.21M2.87%1.26K
Vanguard US Total Market Shares ETF1.14M2.73%-
iShares Russell 2000 ETF931.62K2.22%-
Jennison SMid Cap Core Equity664.86K1.60%-
PGIM Jennison Small Company A664.86K1.58%-
Lord Abbett Developing Growth A564.54K1.34%-4.62K
Vanguard Institutional Extnd Mkt Idx Tr548.01K1.30%4.00K
Macquarie Small Cap Growth C499.15K1.19%-
AZ InvestEd Ivy Small Cap Growth E499.15K1.19%-
MEDICAL BioHealth EUR Acc484.73K1.15%-76.80K

Recent Insider Transactions

DateNameRoleActivityValue
Jun 17, 2025Farrow Jeffrey S See RemarksSell$550.04K
Jun 16, 2025Lin Elizabeth Yeu Chief Medical OfficerSell$41.33K
Jun 09, 2025Mottiwala Aziz Chief Commercial OfficerSell$765.80K
Mar 24, 2025Azamian Bobak R. President/CEO and Board ChairSell$300.00K
Mar 18, 2025Mottiwala Aziz Chief Commercial OfficerSell$168.63K

Insider Transactions Trends

DateBuySell
2025 Q2-3
2025 Q1-19
2024 Q4--
2024 Q3-2
2024 Q2-1

TARS Ownership FAQ

Who Owns Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals shareholders are primarily institutional investors at 110.71%, followed by 3.23% insiders and -13.94% retail investors. The average institutional ownership in Tarsus Pharmaceuticals's industry, Biotech Stocks , is 63.84%, which Tarsus Pharmaceuticals exceeds.

Who owns the most shares of Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals’s largest shareholders are Rtw investments, lp (3.41M shares, 9.67%), Blackrock (3.27M shares, 9.25%), and Blackrock funding, inc. /de (3.54M shares, 9.22%). Together, they hold 28.14% of Tarsus Pharmaceuticals’s total shares outstanding.

Does Blackrock own Tarsus Pharmaceuticals?

Yes, BlackRock owns 9.25% of Tarsus Pharmaceuticals, totaling 3.27M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 88.79M$. In the last quarter, BlackRock increased its holdings by 614.03K shares, a 23.15% change.

Who is Tarsus Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tang capital management is Tarsus Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 8.26% of its assets in 2.25M Tarsus Pharmaceuticals shares, valued at 124.85M$.

Who is the top mutual fund holder of Tarsus Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Tarsus Pharmaceuticals shares, with 2.87% of its total shares outstanding invested in 1.21M Tarsus Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools